Pharmaceutical Industry

Page 11 of 100

Here’s the real reason Ozempic-like weight-loss drugs are so popular
Commentary

Here’s the real reason Ozempic-like weight-loss drugs are so popular

By
August 12, 2024
FDA sign
Health

FDA rejects psychedelic drug MDMA as a treatment for PTSD

By Matthew Perrone and The Associated Press
August 10, 2024
Lars Fruergaard Jorgensen
Health

Wegovy is finally more widely available—and it’s bad news for Novo Nordisk’s profits

By
August 7, 2024
An Ozempic (semaglutide) injection pen is seen on a kitchen table.
Health

How Denmark got homegrown giant Novo Nordisk to lower Ozempic prices

By Arthur Allen and KFF Health News
August 7, 2024
Teens are getting colorectal cancer at unprecedented rates—but a little-known IRA provision is blocking new lifesaving treatments
Commentary

Teens are getting colorectal cancer at unprecedented rates—but a little-known IRA provision is blocking new lifesaving treatments

By
August 2, 2024
How Eli Lilly went from pharmaceutical slowpoke to $791 billion juggernaut
Magazine

How Eli Lilly went from pharmaceutical slowpoke to $791 billion juggernaut

By
August 2, 2024
Only an AI breakthrough can help humans live longer, argues drug developer: ‘We need a ChatGPT moment in longevity’
Conferences

Only an AI breakthrough can help humans live longer, argues drug developer: ‘We need a ChatGPT moment in longevity’

By
July 31, 2024
Angela Fitch. cofounder and chief medical officer of knownwell.
Commentary

I’m an obesity medicine doctor and I’ve been on weight-loss drugs like Ozempic for a decade. Here’s why I think they aren’t a fad

By
July 30, 2024
Thomas Schinecker, chief executive officer of Roche
Finance

Swiss pharma giant Roche is ‘fast-tracking’ development of an experimental Wegovy challenger pill for weight loss

By
July 29, 2024
David Rubenstein
Finance

A CEO abruptly resigned from a board after leaked emails reportedly showed inappropriate influence

By Marion Halftermeyer and Bloomberg
July 26, 2024
Sergey Brin is using money from selling his Tesla shares to bankroll a startup developing hallucinogenic mental-health treatments
Health

Sergey Brin is using money from selling his Tesla shares to bankroll a startup developing hallucinogenic mental-health treatments

By
July 23, 2024
Thomas Schinecker, CEO of Roche Holding.
Retail

An obesity pill study tested on just 25 patients led to a stunning $16.8 billion increase in Swiss drugmaker Roche’s market value

By Naomi Kresge, Lisa Pham and Bloomberg
July 23, 2024
A bathroom scale is surrounded by colorful pills.
Health

Pharma giant Pfizer is trying to cash in on the weight loss drug craze with a new pill that could be a welcome needle-free alternative to pesky GLP-1 shots

By Damian Garde and Bloomberg
July 11, 2024
Why investing in places like Birmingham, Alabama is key to securing U.S. biotech dominance as China tries to close the gap
Commentary

Why investing in places like Birmingham, Alabama is key to securing U.S. biotech dominance as China tries to close the gap

By Katie Britt, Terri Sewell, Kay Ivey and Randall Woodfin
July 3, 2024
Alzheimer’s made my mom unable to recognize her grandkids. Breakthroughs too late for her can change the disease’s trajectory—if diagnosis and treatment start early
Commentary

Alzheimer’s made my mom unable to recognize her grandkids. Breakthroughs too late for her can change the disease’s trajectory—if diagnosis and treatment start early

By
July 2, 2024

Most Popular